Aita i maoro a'e, kitea kairangahau i China Medical University Taiwan he whakamahi noa o te konutai benzoate rite te rokiroki kai i roto i te maimoatanga o te wairua tuakoi. Maoro whakaputaina i roto i te koiora Psychiatry tika "Sodium Benzoate, he D-Amino Waikawa oxidase inhibitor, apititia ki Clozapine mo te Treatment o Tuakoi: A randomized, Double-matapo, Trial placebo-te mana [Sodium Benzoate, ngā te waikawa oxidase inhibitor D-amino ki clozapine i roto i te maimoatanga o te wairua tuakoi: he randomized, placebo-te mana, rua-matapo ako haumanu] whakaatu tuhinga e he whakangutungutu ki ātete clozapine e tōtika ake te tohu o te mate i roto i te rōpū o te tūroro ki te tuakoi konutai benzoate.
No nia i te hua o te ako, John Krystal, MD, ētita o koiora Neurology me ahorangi i Yale University School o Medicine, kī atu e receptors D-serine ko te ūnga whakaora roa-tu i roto i te whanaketanga o te raau taero tuakoi mo nga tau. Ko pea Konutai benzoate te taputapu e whai hua tuatahi to tatou ki te whakaawe kaha tenei ūnga.
Shijiazhuang Paerewa matū Co., mätanga LTD i te hanga me te kaweake o te konutai benzoate, ka hoatu e matou a koutou hua kounga teitei, me te mahi pai. kiritaki Nau mai ki te whiriwhiri.
wā Post: Mei-11-2018